Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study (Q44035070)

29 November 2017

Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study (English)

1 reference

29 November 2017

1 reference

M F Erdogan

1

1 reference

29 November 2017

A Gürsoy

2

1 reference

29 November 2017

G Ozgen

3

1 reference

29 November 2017

M Cakir

4

1 reference

29 November 2017

F Bayram

5

1 reference

29 November 2017

R Ersoy

6

1 reference

29 November 2017

E Algün

7

1 reference

29 November 2017

B Cetinarslan

8

1 reference

29 November 2017

A Cömlekçi

9

1 reference

29 November 2017

P Kadioglu

10

1 reference

29 November 2017

M K Balci

11

1 reference

29 November 2017

I Yetkin

12

1 reference

29 November 2017

T Kabalak

13

1 reference

29 November 2017

G Erdogan

14

1 reference

29 November 2017

1 October 2005

1 reference

Journal of Endocrinological Investigation

29 November 2017

1 reference

29 November 2017

28

1 reference

29 November 2017

9

1 reference

29 November 2017

806-809

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03347570

29 November 2017

0 references

cites work

Medullary thyroid carcinoma: recent advances and management update

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Renal agenesis and the absence of enteric neurons in mice lacking GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Clinical management of the multiple endocrine neoplasia syndromes: results of a computerized opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Erratum: A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC: s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347570

A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor

21 January 2018

1 reference

12 December 2020

Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1 reference

12 December 2020

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

12 December 2020

RET proto-oncogene mutations in French MEN 2A and FMTC families

1 reference

12 December 2020

Surgical treatment of medullary thyroid carcinoma

1 reference

12 December 2020

Multiple endocrine neoplasia type 2. Clinical features and screening.

1 reference

12 December 2020

Defects in enteric innervation and kidney development in mice lacking GDNF

1 reference

12 December 2020

Multiple endocrine neoplasia type 2: management of patients and subjects at risk. French Study Group on Calcitonin-Secreting Tumors (GETC).

1 reference

12 December 2020

Medullary thyroid carcinoma

1 reference

12 December 2020

Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes

1 reference

12 December 2020

RET proto-oncogene in the development of human cancer

1 reference

12 December 2020

Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347570

1 reference

29 November 2017

1 reference